Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding

Student Poster

(6-154) Lerodalcibep: A Novel Third-Generation Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor for Hypercholesteremia in Patients with Atherosclerotic Cardiovascular Disease

Tuesday, December 10, 2024
10:45 AM – 11:45 AM  
Location: Hall G, Lower Level
Category: Descriptive Report
Topic: Clinical Topics/Therapeutics
Co-Author(s): Kaiya Clements, Jeremy Johnson, Michaela Lombardi